Innovative development of probiotic food supplement products and clinical trials for reducing the risk factor of noncommunicable diseases

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

TCTR

Registry ID

TCTR20230715001

Enrollment

150

Registered

2023-07-15

Start date

2021-09-16

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Volunteers 18-60 years with LDL more than 130 mg/dl , or triglycerides more than 150 mg/dl , or fasting plasma glucose ranging 100-125 mg/dl Probiotics, noncommunicable diseases, food supplements, functional ingredients

Interventions

Probiotic strain: Lactobacillus paracasei MSMC39-1 Capsule once daily,Probiotic strain: Bifidobacterium animalis MSMC83 Capsule once daily ,Probiotic 2 strains: L. paracasei MSMC39-1 + B. animalis MSM

Experimental Dietary Supplement,Experimental Dietary Supplement,Experimental Dietary Supplement,Experimental Dietary Supplement,Placebo Comparator No treatment

Probiotic strain: Lactobacillus paracasei MSMC39-1,Probiotic strain: Bifidobacterium animalis MSMC83,Probiotic 2 strains: L. paracasei MSMC39-1 + B. animalis MSMC83,Probiotic 3 strains: L. paracasei M

Eligibility

Sex/Gender

All

Age

18 Years to 60 Years

Inclusion criteria

Inclusion criteria: Volunteers 18-60 years with LDL more than 130 mg/dl , or triglycerides more than 150 mg/dl , or fasting plasma glucose ranging 100-125 mg/dl

Exclusion criteria

Exclusion criteria: Underlying of Diabetes, Hypertension Cardiovascular diseases Cancer Liver diseases Immunodeficiency Pregnancy

Design outcomes

Primary

Measure	Time frame
LDL, Triglycerides, Fasting blood sugar 12 weeks LDL, Triglycerides, Fasting blood sugar (Mg/dl)	—

Secondary

Measure	Time frame
Blood test for Triglycerides (mg/dl) 12 weeks Blood test for Triglycerides (mg/dl)	—

Countries

Thailand

Contacts

Public ContactAssoc.Prof.Malai Taweechotipatr

Faculty of Medicine, Srinakharinwirot University

malai@g.swu.ac.th0860961314

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026